JP2008525033A5 - - Google Patents

Download PDF

Info

Publication number
JP2008525033A5
JP2008525033A5 JP2007548453A JP2007548453A JP2008525033A5 JP 2008525033 A5 JP2008525033 A5 JP 2008525033A5 JP 2007548453 A JP2007548453 A JP 2007548453A JP 2007548453 A JP2007548453 A JP 2007548453A JP 2008525033 A5 JP2008525033 A5 JP 2008525033A5
Authority
JP
Japan
Prior art keywords
nucleic acid
polypeptide
group
seq
nos
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007548453A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008525033A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/046491 external-priority patent/WO2006069200A2/en
Publication of JP2008525033A publication Critical patent/JP2008525033A/ja
Publication of JP2008525033A5 publication Critical patent/JP2008525033A5/ja
Pending legal-status Critical Current

Links

JP2007548453A 2004-12-22 2005-12-21 Ｂ群連鎖球菌 Pending JP2008525033A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63894304P 2004-12-22 2004-12-22
US64043804P 2004-12-30 2004-12-30
PCT/US2005/046491 WO2006069200A2 (en) 2004-12-22 2005-12-21 Group b streptococcus

Publications (2)

Publication Number Publication Date
JP2008525033A JP2008525033A (ja) 2008-07-17
JP2008525033A5 true JP2008525033A5 (enExample) 2009-07-23

Family

ID=36602309

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007548453A Pending JP2008525033A (ja) 2004-12-22 2005-12-21 Ｂ群連鎖球菌

Country Status (8)

Country Link
US (1) US20090104218A1 (enExample)
EP (1) EP1828231A2 (enExample)
JP (1) JP2008525033A (enExample)
AU (1) AU2005319174A1 (enExample)
CA (1) CA2591510A1 (enExample)
IL (1) IL183830A0 (enExample)
MX (1) MX2007007033A (enExample)
WO (1) WO2006069200A2 (enExample)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU776735B2 (en) 1998-12-22 2004-09-23 Microscience Limited Genes and proteins, and their use
US6890539B2 (en) 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
WO2002034771A2 (en) 2000-10-27 2002-05-02 Chiron Srl Nucleic acids and proteins from streptococcus groups a & b
ES2505695T3 (es) 2003-07-31 2014-10-10 Novartis Vaccines And Diagnostics, Inc. Composiciones inmunógenas para Streptococcus pyogenes
US8945589B2 (en) 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
WO2006042027A2 (en) * 2004-10-08 2006-04-20 Novartis Vaccines And Diagnostics Inc. Immunogenic and therapeutic compositions for streptococcus pyogenes
EP1801235A1 (en) * 2005-12-20 2007-06-27 Institut Pasteur Rapid detection of the "high virulent" ST-17 clone of Group B streptococcus
US20100261618A1 (en) * 2006-06-19 2010-10-14 Sonia Escaich Identification of genes implicated in the virulence of streptococcus agalactiae
WO2009027768A2 (en) * 2006-07-26 2009-03-05 Novartis Ag Immunogenic compositions for gram positive bacteria
CN101969992B (zh) 2007-09-12 2014-10-01 诺华股份有限公司 Gas57突变型抗原和gas57抗体
EP2135877A1 (en) 2008-06-19 2009-12-23 Helmholtz-Zentrum für Infektionsforschung GmbH Marker of steptococcus anginosus/Streptococcus constellatus (Moac) and uses thereof
US8147849B2 (en) 2009-02-20 2012-04-03 Novartis Ag Protective antigens for group B Streptococcus hypervirulent strains
ITMI20090946A1 (it) 2009-05-28 2010-11-29 Novartis Ag Espressione di proteine ricombinanti
MX2012000158A (es) 2009-06-29 2012-06-08 Genocea Biosciences Inc Vacunas y composiciones contra streptococcus pneumoniae.
GB201101665D0 (en) 2011-01-31 2011-03-16 Novartis Ag Immunogenic compositions
AU2012207089B2 (en) 2011-01-20 2016-04-14 Children's Medical Center Corporation Vaccines and compositions against Streptococcus pneumoniae
WO2012105595A1 (ja) * 2011-02-02 2012-08-09 公益財団法人微生物化学研究会 血液脳関門を透過する薬物輸送体、ペプチド及びその用途
EP2557424A1 (en) * 2011-08-11 2013-02-13 InGen Biosciences Method for diagnosing Streptococcus, Enterococcus and Pepstostreptococcus genera infections
AU2013224026A1 (en) * 2012-02-24 2014-08-21 Novartis Ag Pilus proteins and compositions
US8865435B2 (en) * 2012-03-30 2014-10-21 E. I. Du Pont De Nemours And Company Enzymes useful for peracid production
SG11201500978TA (en) 2012-10-03 2015-07-30 Glaxosmithkline Biolog Sa Immunogenic compositions
EP3021864A1 (en) * 2013-07-16 2016-05-25 Université de Lausanne Bacterial lysins and uses thereof
AR101455A1 (es) * 2014-08-05 2016-12-21 Glaxosmithkline Biologicals Sa Molécula portadora
CA3013527C (en) 2016-02-04 2023-09-05 Genovis Ab New streptococcal proteases
US11028159B2 (en) 2017-05-02 2021-06-08 Venomyx, Inc. Composition and methods for treating snake envenomation
WO2018237010A2 (en) * 2017-06-20 2018-12-27 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Vaccine compositions and methods of using the same
PL239045B1 (pl) * 2018-01-09 2021-11-02 Inst Immunologii I Terapii Doswiadczalnej Polskiej Akademii Nauk Epitop specyficzny dla zakaźnych Streptococcus agalactiae oraz sposób wykrywania zakażenia pacjenta szczepem Streptococcus agalactiae
US11453919B2 (en) * 2018-06-13 2022-09-27 Gen-Probe Incorporated Compositions and methods for detecting group B Streptococcus nucleic acid
JP7289158B2 (ja) 2018-08-06 2023-06-09 メディカイン、インコーポレイテッド Ｉｌ－２受容体結合化合物
JP7427286B2 (ja) 2019-11-05 2024-02-05 メディカイン、インコーポレイテッド ＩＬ－２ＲβγＣ結合化合物
IL293553A (en) * 2019-12-06 2022-08-01 Theratechnologies Inc Sortilin binding conjugate compounds, compositions and uses thereof for treating cancer
BR112022015002A2 (pt) 2020-02-03 2022-12-06 Medikine Inc Ligante de il-7r-alfa/gama/c, composto, composição farmacêutica, método para tratar uma doença em um paciente e ácido nucleico
US20230127948A1 (en) * 2020-02-12 2023-04-27 The Broad Institute, Inc. Field deployable crispr-cas diagnostics and methods of use thereof
US11453907B2 (en) 2020-03-23 2022-09-27 The Broad Institute, Inc. Crispr effector system based coronavirus diagnostics
WO2022026534A1 (en) * 2020-07-28 2022-02-03 Kansas State University Research Foundation Sars-cov-2 immunogenic compositions and methods for protecting against sars-cov-2 clinical signs
EP4268901A3 (en) * 2020-11-04 2024-01-17 Medikine, Inc. Il-2r beta-gamma c binding compounds and uses thereof
US11999771B2 (en) 2022-04-07 2024-06-04 Medikine, Inc. IL-7Rαγc ligand immunoglobulin fusion proteins
WO2025017062A1 (en) * 2023-07-18 2025-01-23 Intervet International B.V. New type of streptococcus agalactiae serotype ia bacterium and vaccines thereof
WO2025151408A1 (en) * 2024-01-08 2025-07-17 Denali Therapeutics Inc. Compositions and methods for modulating tau expression
WO2025250877A1 (en) * 2024-05-31 2025-12-04 Saliogen Therapeutics, Inc. Mobile genetic elements from myotis myotis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL95578A (en) * 1989-09-15 1998-08-16 Gen Hospital Corp Conjugate vaccine formed from a polysaccharide and a c protein of b-streptococcus
GB9808327D0 (en) * 1998-04-20 1998-06-17 Chiron Spa Antidiotypic compounds
JP2002531054A (ja) * 1998-07-27 2002-09-24 マイクロビアル テクニクス リミティッド Ｂ群連鎖球菌由来の核酸およびタンパク質
GB9921125D0 (en) * 1999-09-07 1999-11-10 Microbial Technics Limited Proteins
WO2002034771A2 (en) * 2000-10-27 2002-05-02 Chiron Srl Nucleic acids and proteins from streptococcus groups a & b
FR2824074A1 (fr) * 2001-04-26 2002-10-31 Pasteur Institut Sequence du genome streptococcus agalactiae, application au developpement de vaccins, d'outils de diagnostic, et a l'identification de cibles therapeutiques
AU2003274011B2 (en) * 2002-10-15 2010-03-04 Intercell Ag Nucleic acids coding for adhesion factor of group B streptococcus, adhesion factors of group B streptococcus and further uses thereof
GB0227346D0 (en) * 2002-11-22 2002-12-31 Chiron Spa 741

Similar Documents

Publication Publication Date Title
JP2008525033A5 (enExample)
JP2008538183A5 (enExample)
JP2012000112A5 (enExample)
RU2007139915A (ru) Haemophilus influenzae типа в
JP2010166916A5 (enExample)
RU2006144093A (ru) Полипептиды нетипируемой haemophilus influenzae
JP2008529558A5 (enExample)
JP2005511076A5 (enExample)
JP2003527079A5 (enExample)
JP2010273685A5 (enExample)
JP2008508859A5 (enExample)
JP2012505657A5 (enExample)
RU2012102339A (ru) Полипептиды из neisseria meningitidis
JP2011004753A5 (enExample)
JP2006516189A5 (enExample)
JP2012126742A5 (enExample)
JP2010532657A5 (enExample)
JP2002542827A5 (enExample)
JP2007502101A5 (enExample)
EP2292648A3 (en) Small Streptococcus pyogenes antigens and their use
JP2015514132A5 (enExample)
JP2013523718A5 (enExample)
JP2019534884A5 (enExample)
JP2015533791A5 (enExample)
JP2010517544A5 (enExample)